Melissa Badowski
Clinical Professor, Pharmacy Practice
Contact
Office Phone:
Email:
Related Sites:
About Heading link
Teaching and Supervision Heading link
Spec Project in Pharm Pract (PMPR 390), 8/21/2023 – 12/1/2023
Management of the HIV Patient (PMPR 338), 8/21/2023 – 12/1/2023
Management of the HIV Patient (PMPR 338), 8/21/2023 – 12/1/2023
Clinical Research Design (PMPR 487), 1/9/2023 – 4/28/2023
PhLAMES 8 (PHAR 472), 1/9/2023 – 4/28/2023
Spec Project in Pharm Pract (PMPR 390), 1/9/2023 – 4/28/2023
Exploration of Telemedicine (PMPR 339), 1/9/2023 – 4/28/2023
Exploration of Telemedicine (PMPR 339), 1/9/2023 – 4/28/2023
Exploration of Telemedicine (PMPR 339), 1/9/2023 – 4/28/2023
Selected Grants
CTA - Observational Cohort Study of Cabenuva Utilization, Outcomes, and Patient Experience in the United States (BEYOND), Research Triangle Inst., 9/30/2021 - 3/29/2022, Obligated Amount: $28904; Anticipated Amount: $28904
Assessing Long Term Weight Changes in Persons with Early and Substantial Weight Gain on Integrase Inhibitor Containing Antiretroviral Therapy, Thomas Jefferson University., 7/1/2021 - 6/30/2022, Obligated Amount: $13000; Anticipated Amount: $13000
The incidence and severity of drug interactions before and after switching antiretroviral therapy to bictegravir/emtricitabine/tenofovir alafenamide in treatment experienced patients, Thomas Jefferson University., 11/26/2019 - 11/25/2024, Obligated Amount: $10400; Anticipated Amount: $10400
Gilead Sciences, Inc., 1/1/2019 - 12/31/2019, Obligated Amount: $10400; No Anticipated Amount Set
Gilead Sciences, Inc., 1/1/2019 - 12/31/2019, Obligated Amount: $10400; No Anticipated Amount Set
Evaluation of Safety and Efficacy of First-Line Antiretroviral and Single Tablet Regimens (STR) in the Correctional: Is One Table Once Daily Really the Best Options?, Bristol-Myers Squibb., 3/25/2014 - 5/15/2015, Obligated Amount: $20000; Anticipated Amount: $20000
Bristol Myers Squibb., 8/1/2013 - 5/15/2015, Obligated Amount: $20000; No Anticipated Amount Set
Bristol Myers Squibb., 8/1/2013 - 5/15/2015, Obligated Amount: $20000; No Anticipated Amount Set
American Academy of HIV Medicine / Institute of Technology., 3/3/2013 - Present, Obligated Amount: $10000; No Anticipated Amount Set
Selected Publications
Badowski, Melissa, Kassem, Sally, Labedz, Malgorzata, Taylor, Christopher, Bunnell, Kristen, Hall, Ashley, Darnell, Hannah, Huesgen, Emily. (2023). Virologic outcomes of antiretroviral therapy in patients with HIV-1 following bariatric surgery: A case series and review of the literature.. International Journal of STD & AIDS, 9564624231213114. doi:10.1177/09564624231213114.
Brizzi, Marisa, Sherman, Elizabeth M, Green, Sarah B, Nowicki, Diana N, Drwiega, Emily N, Nicol, Melanie R, Chastain, Daniel B, Sahloff, Eric G, Truong, William R, Cluck, David, Badowski, Melissa E, Michienzi, Sarah M, Durham, Spencer H. (2023). Personalizing prevention: Advances in pharmacotherapy for HIV prevention. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, 43, (4), 305-320. doi:10.1002/phar.2796.
Hanson, Hali A, Kim, Eunice, Badowski, Melissa E. (2023). A Systematic Review: Impact of SARS-CoV-2 Infection on Morbidity, Mortality, and Viral Suppression in Patients Living With HIV. SN Comprehensive Clinical Medicine, 5, (1), 144. doi:10.1007/s42399-023-01480-6.
Brizzi, Marisa, Pérez, Sarah E, Michienzi, Sarah M, Badowski, Melissa E. (2023). Long-acting injectable antiretroviral therapy: will it change the future of HIV treatment?. Therapeutic Advances in Infectious Disease, 10, 20499361221149773. doi:10.1177/20499361221149773.
Januszka, Jenna, Drwiega, Emily N, Drwiega, Emily N, Burgos, Rodrigo M, Michienzi, Sarah M, Smith, Renata, Badowski, Melissa E. (2022). 2060. Evaluation of the real world incidence of integrase inhibitor resistance since adoption as guideline preferred therapy. Open Forum Infectious Diseases, 9, (Suppl 2), ofac492.1682. doi:10.1093/ofid/ofac492.1682.
Patel, Dimple, Michienzi, Sarah M, Borgetti, Scott, Patel, Mahesh C, Zheng, Anne, Zhu, Michael, Badowski, Melissa E. (2022). 1103. Virologic and Immunologic Outcomes in People Living with HIV in a Correctional Setting During the SARS-CoV-2 Pandemic. Open Forum Infectious Diseases, 9, (Supplement_2). doi:10.1093/ofid/ofac492.942.
Badowski, Melissa E, Patel, Mahesh. (2022). Evaluation of Immunologic and Virologic Function in Reincarcerated Patients Living With HIV or AIDS. Journal of Correctional Health Care, 28, (3), 203-206. doi:10.1089/jchc.20.07.0055.
Idrees, Niha, Hwang, Yu Jin, Arman, Sabreen, Hendi, Razan, Michienzi, Sarah M, Patel, Mahesh C, Borgetti, Scott, Badowski, Melissa E. (2021). 879. Evaluation of the Incidence of Hypertension, Diabetes, and Hyperlipidemia in Patients on Antiretroviral Therapy. Open Forum Infectious Diseases, 8, (Supplement_1), s531-s531. doi:10.1093/ofid/ofab466.1074.
O’Brien, Kathryn M, Badowski, Melissa E, Bartoo, Anna S, Peppard, William J, Schwarz, Kerry, Sharpe, Abigail R, Szwak, Jennifer Austin. (2021). Determining support for and barriers to pharmacist‐driven research: Results of a national survey. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 4, (12), 1534-1539. doi:10.1002/jac5.1523.
Education
Degrees:
Master in Public Health, University of Illinois at Chicago, United States, 2017
Doctor of Pharmacy, Magna Cum Laude, Midwestern University, United States, 2006
Licensures and Certifications
Certificate in Pharmacoepidemiology, University of Illinois at Chicago, 2017 - Present
Teaching and Learning Certificate, American College of Clinical Pharmacy, 2014 - Present
Educational Theory and Practice Certificate, University of Maryland, 2007 - Present
Pharmacist, Registered, State of Maryland, 2006 - Present
Pharmacist, Registered, State of Illinois, 2006 - Present
Board Certified Infectious Diseases Pharmacist, n/a, Date Not Set - Present
Practicing HIV Pharmacist, American Academy of HIV Medicine, 2009 - Present
Board Certified Pharmacotherapy Specialist, n/a, 2008 - Present
Basic Life Support and AED Certification for Healthcare Providers, n/a, 2006 - Present